IKZF1 and Miyoshi myopathy: Additionally, a 48-hour PDS treatment led to a 50% decrease in the messenger RNA (mRNA) production of major MM oncogenes, namely MYC and IRF4, together with IKZF1 transcription factor regulating IRF4 and Myc expression (Figure 3D).31